Sign in

CIK 0000907654

  • Non-accelerated filer
  • Smaller reporting company

Oruka Therapeutics, Inc.

Sign in to watch
Ticker
ORKA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
363855489
Phone
+1 650-606-7910
Business address
855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
Former names
ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$21,431,111
in 18 filings, $21.0M under 10b5-1 plans

Net −$21,431,111. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2008-06-04 PERRY MARK L Director Grant or award · Non-Qualified Stock Option (right to buy) +15,000 15,000
2007-05-31 PERRY MARK L Director Grant or award · Non-Qualified Stock Option (right to buy) +15,000 15,000
2006-09-28 PERRY MARK L Director Exercise or conversion +3,333 $9.12 $30K 3,333
2006-09-28 PERRY MARK L Director Exercise or conversion +7,500 $11.11 $83K 10,833
2006-09-28 PERRY MARK L Director Exercise or conversion +25,000 $6.50 $163K 35,833
2006-09-28 PERRY MARK L Director Exercise or conversion +15,000 $6.73 $101K 50,833
2006-09-28 PERRY MARK L Director Exercise or conversion +15,000 $14.66 $220K 65,833
2006-05-24 PERRY MARK L Director Grant or award · Non-Qualified Stock Option (right to buy) +15,000 15,000
2005-05-24 PERRY MARK L Director Grant or award · Non-Qualified Stock Option (right to buy) +15,000 15,000
2005-03-23 PERRY MARK L Director Grant or award · Non-Qualified Stock Option (right to buy) +25,000 25,000
2004-05-06 PERRY MARK L Director Grant or award · Non-Qualified Stock Option (right to buy) +7,500 7,500
2003-10-13 PERRY MARK L Director Grant or award · Non-Qualified Stock Option (right to buy) +10,000 10,000

Page 1 of 1 · 12 trades